13F-HR filed by Omega Fund Management, LLC
Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-05, with 12 holding rows worth $138,312,000.
- Accession
- 0000950123-18-000798
- Filer
- CIK 1637359
- Filed
- 2018-02-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 12 entries on the cover page, a total value of $138,312,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $138,312,000 with VALUE read as thousands by filing date, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 2,600,410 | $46,547,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 753,564 | $34,445,000 | thousands by filing date | |
| SIENNA BIOPHARMACEUTICALS IN | 82622H108 | COM | 758,610 | $13,769,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 1,000,000 | $9,760,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 579,650 | $7,391,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 904,053 | $6,826,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 130,646 | $6,193,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 551,477 | $5,074,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 444,965 | $3,026,000 | thousands by filing date | |
| EGALET CORP | 28226B104 | COM | 2,889,926 | $2,890,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 223,457 | $2,018,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H104 | COM | 1,696,969 | $373,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-18-000798 | this filing | 2018-02-05 | acceptance time not in the bulk data set |